AMEND is supporting a free one-day scientific meeting at the Francis Crick Institute in London on Monday 10 June. RET@CRICK will explore the different expressions of the RET protein. RET is involved in a diverse range of diseases, including NET syndromes, multiple endocrine neoplasia type 2, medullary thyroid cancer, Hirschsprung’s disease, lung cancer, Parkinson’s disease and pituitary disease. A world-leading line-up of both clinical and research speakers will explore RET’s diversity and how researchers may be able to work in synergy. For more information and to book a free place, visit RET@CRICK’s website. The event is also sponsored by the Francis Crick Institute, the Society for Endocrinology, Blueprint Medicines and Fight for Life.